本頁面由Tiger Trade Technology Pte. Ltd.提供服務

再鼎醫藥

19.02
-0.0400-0.21%
盤後19.020.00000.00%16:10 EDT
成交量:59.34萬
成交額:1,127.17萬
市值:21.11億
市盈率:-11.87
高:19.13
開:18.91
低:18.75
收:19.06
52周最高:44.34
52周最低:15.96
股本:1.11億
流通股本:1.09億
量比:1.30
換手率:0.54%
股息:- -
股息率:- -
每股收益(TTM):-1.6026
每股收益(LYR):-1.6026
淨資產收益率:-22.56%
總資產收益率:-12.16%
市淨率:2.95
市盈率(LYR):-11.87

資料載入中...

2024/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/06

重要事件披露

Form 8-K - Current report
2024/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/09

重要事件披露

Form 8-K - Current report
2024/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/18

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/06/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities